Quintiles deepens Malaysian foothold

Contract research organization Quintiles has signed a deal with University Malaya Medical Center in Malaysia to create the company’s first prime site in Asia.

Prime sites are larger clinical institutions that work with Quintiles to conduct clinical trials. The CRO already has prime sites at Queen Mary’s College in London, the Washington Hospital Center in Washington, D.C., the University of Pretoria in South Africa and the Southern California Permanente Medical Group.

“Malaysia is an increasingly important player in Asia-Pacific clinical drug development and the commitment of its government, academic and private industry leaders to promoting leading-edge clinical research in the country is undeniable, “ said Dr payday loan companies. Anand Tharmaratnam, senior vice president and head of clinical development for Quintiles Asia-Pacific. “This, coupled with the highly skilled clinical workforce, strong clinical research infrastructure and large potential patient populations makes Malaysia and UMMC a quality fit as our first Prime Site in Asia.”

Quintiles, which is based in Research Triangle Park, employs about 1,400 in the Triangle.

Source

Comments are closed.